Stockscreener 앱 받기
53.90
7.21%
-4.19
시간 외 거래:
53.90
전일 마감가:
$58.09
열려 있는:
$55.38
하루 거래량:
2.07M
Relative Volume:
1.47
시가총액:
$4.58B
수익:
-
순이익/손실:
$-153.72M
주가수익비율:
-26.95
EPS:
-2
순현금흐름:
$-103.81M
1주 성능:
-14.04%
1개월 성능:
-20.15%
6개월 성능:
+68.38%
1년 성능:
+225.88%
1일 변동 폭
$52.93
$56.48
1주일 범위
$52.93
$63.75
52주 변동 폭
$11.39
$70.40
Verona Pharma Plc Adr Stock (VRNA) Company Profile
명칭
Verona Pharma Plc Adr
전화
011-44-0-2032834200
주소
3 MORE LONDON RIVERSIDE, LONDON
VRNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRNA
Verona Pharma Plc Adr
|
53.90 | 4.58B | 0 | -153.72M | -103.81M | -2.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | ROTH MKM | Buy |
| 2024-10-03 | 개시 | Wells Fargo | Overweight |
| 2023-05-22 | 재개 | Jefferies | Buy |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-08-26 | 개시 | Piper Sandler | Overweight |
| 2021-09-13 | 개시 | H.C. Wainwright | Buy |
| 2020-08-25 | 개시 | Jefferies | Buy |
| 2020-08-10 | 개시 | Canaccord Genuity | Buy |
| 2019-04-18 | 개시 | BTIG Research | Buy |
모두보기
Verona Pharma Plc Adr 주식(VRNA)의 최신 뉴스
Verona Pharma secures $450 million credit facility on better terms By Investing.com - Investing.com South Africa
Verona Pharma secures $450 million credit facility on better terms - Investing.com
The growth track for Cracker Barrel Old Country Store Inc (CBRL) has changed recently - SETE News
Verona Pharma Plc ADR (NASDAQ: VRNA) Up 298.80% This Year: What Is Going To Happen Next - Stocks Register
Verona Pharma’s chief medical officer sells shares worth $661,941 By Investing.com - Investing.com South Africa
Verona Pharma’s chief medical officer sells shares worth $661,941 - Investing.com India
Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity - Knox Daily
McEwen Mining Inc (MUX) Becoming More Attractive for Investors - Knox Daily
Morgan Stanley Upgrades Solaredge Technologies Inc (SEDG) to an Equal-weight from an Underweight - Knox Daily
Verona Pharma at Leerink Global Healthcare: Eutuvera’s Promising Launch By Investing.com - Investing.com UK
Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa
Verona Pharma stock surges as Q4 revenue soars past estimates - Investing.com India
Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada
Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com
Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript - MSN
Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK
A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily
Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - GlobeNewswire Inc.
Verona Pharma stock soars to all-time high of $62.09 - Investing.com India
Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa
Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa
Investor’s Delight: Lithium Americas Corp (NewCo) (LAC) Closes Weak at 2.97, Down -1.98 - The Dwinnex
There is no doubt that Verona Pharma Plc ADR (VRNA) ticks all the boxes. - SETE News
Analyzing Verona Pharma Plc ADR (VRNA) After Recent Trading Activity - Knox Daily
Rumble Inc (RUM)’s Market Momentum: Closing Strong at 12.25, Down -3.92 - The Dwinnex
Market Recap Check: Lineage Cell Therapeutics Inc (LCTX)’s Negative Finish at 0.66, Up/Down -2.12 - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: OrganiGram Holdings Inc (OGI) - SETE News
Are Smart Investors Making the Right Decision? Verona Pharma Plc ADR (VRNA) - SETE News
Healthy Upside Potential: Solidion Technology Inc (STI) - SETE News
Stock Surge: XPO Inc (XPO) Closes at 131.50, Marking a 2.24 Increase/Decrease - The Dwinnex
Closing Figures Unveiled: Diageo plc ADR (DEO) Drop -0.84, Closes at 115.95 - The Dwinnex
Market Watch Highlights: Verona Pharma Plc ADR (VRNA) Ends on an Upturn Note at 59.94 - The Dwinnex
Market Momentum Report: Lemonade Inc (LMND)’s Positive Close at 33.99 - The Dwinnex
Stock Market News and Commentary - Barchart
Verona Pharma Keeps Hitting New Highs - Barchart
An Analysis of Knowles Corp (KN)’s Potential Price Growth - Knox Daily
Checking in on Verona Pharma Plc ADR (VRNA) after recent insiders movement - Knox Daily
A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News
Have you been able to find a good deal on Verona Pharma Plc ADR’s shares? - US Post News
The Agilon Health Inc (AGL) had a good session last reading, didn’t it? - US Post News
How should investors view Relay Therapeutics Inc (RLAY)? - US Post News
Verona Pharma stock target upgraded, retains buy on Q4 results - MSN
Verona Pharma stock target upgraded, retains buy on Q4 results By Investing.com - Investing.com South Africa
Looking For A Top Momentum Pick? Why Valley National Bancorp (NASDAQ: VLY) Is A Great Choice - Stocks Register
Hertz Global Holdings Inc (NASDAQ: HTZ): Overvalued Compared To Others? - Stocks Register
Verona Pharma Plc ADR (VRNA) Outlook: Looking Back For Insights - Stocks Register
Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week - Yahoo! Voices
Verona Pharma stock target increased, keeps buy on Q4 sales By Investing.com - Investing.com South Africa
Verona Pharma stock soars to all-time high of $49.05 - Investing.com India
Here are some of BTIG's top picks for the first half of 2025 - Investing.com
Verona Pharma stock soars to all-time high of $47 amid robust gains By Investing.com - Investing.com South Africa
Verona Pharma Plc Adr (VRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):